TMPRSS2 and COVID-19: Inhibitors of TMPRSS2 have demonstrated potential for preventing viral activation and dissemination, emphasizing the requirement for additional studies to develop efficient antiviral methods toward respiratory tract viruses like COVID-19 and influenza.